Paul Carpenter, MB.BS.

Dr. Paul Carpenter leads research and clinical care teams that support bone marrow and stem cell transplant survivors long after they finish initial treatment. As director of the world-class post-transplant Adult Clinical Care Long-Term Follow-Up Program, known as the LTFU, Dr. Carpenter and his colleagues are helping transplant survivors and their primary care physicians manage post-treatment complications as patients recover and resume their lives. The LTFU also serves as a model for the training of transplant physicians. In his own research, Dr. Carpenter is developing better treatments for graft-vs.-host disease. GVHD is a common complication of bone marrow transplantation that can cause serious illness and even death. In GVHD, donor immune cells attack the patient’s healthy cells. Dr. Carpenter leads clinical trials of new therapies for acute and chronic GVHD. He is studying new ways to overcome long-term complications of GVHD treatments and prevent relapse after transplant.